4//SEC Filing
Levine James E. 4
Accession 0001628280-21-013754
CIK 0001213037other
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:16 PM ET
Size
5.5 KB
Accession
0001628280-21-013754
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Common Stock
2021-07-12+390,000→ 390,000 totalExercise: $6.55Exp: 2031-07-12→ Stock Options (390,000 underlying)
Footnotes (1)
- [F1]97,500 vest on 7/12/2022. 8,125 vest monthly for 36 months beginning on 8/12/2022 through 7/12/2025.
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001463151
Filing Metadata
- Form type
- 4
- Filed
- Jul 11, 8:00 PM ET
- Accepted
- Jul 12, 4:16 PM ET
- Size
- 5.5 KB